Glucose-6-Phosphate Dehydrogenase Deficiency Is Associated With Increased Risk of Acute Kidney Injury Independent of Hemolytic Complications in Children With Severe Malaria - Scorecard - MDSpire

Glucose-6-Phosphate Dehydrogenase Deficiency Is Associated With Increased Risk of Acute Kidney Injury Independent of Hemolytic Complications in Children With Severe Malaria

  • By

  • Ruth Namazzi

  • Caroline Kazinga

  • Giselle Lima-Cooper

  • Claire Liepmann

  • Michael J Goings

  • Olivia Bednarski

  • Marco Abreu

  • Tae-Hwi Schwantes-An

  • Anthony Batte

  • Robert O Opoka

  • Chandy C John

  • Andrea L Conroy

  • February 18, 2025

  • 0 min

Share

Clinical Scorecard: Association of Glucose-6-Phosphate Dehydrogenase Deficiency with Elevated Acute Kidney Injury Risk in Pediatric Severe Malaria, Regardless of Hemolytic Events

At a Glance

CategoryDetail
ConditionAcute kidney injury (AKI) in pediatric severe malaria
Key MechanismsG6PD deficiency leads to increased AKI risk via oxidative stress and hemoprotein release from hemolysis, independent of hemolytic markers
Target PopulationChildren aged 6 months to 4 years with severe malaria in sub-Saharan Africa
Care SettingHospital inpatient care in malaria-endemic regions

Key Highlights

  • G6PD African allele (A−) prevalence: 16.7% in hemizygous males, 2.4% in females among children with severe malaria
  • G6PD deficiency associated with 2.56-fold increased odds of AKI after adjusting for confounders
  • AKI in severe malaria is multifactorial, involving oxidative stress and hemoprotein-mediated tubular injury

Guideline-Based Recommendations

Diagnosis

  • Use KDIGO criteria to define AKI based on a 1.5-fold increase in creatinine from estimated baseline
  • Screen for G6PD deficiency using genetic testing for G6PD A− allele (rs1050828) in pediatric severe malaria patients

Management

  • Monitor kidney function closely in children with severe malaria, especially those with G6PD deficiency
  • Avoid oxidative stress-inducing drugs and infections that may precipitate hemolysis in G6PD-deficient patients

Monitoring & Follow-up

  • Assess markers of hemolysis (haptoglobin, hemopexin, hemin, cell-free hemoglobin, sCD163) to evaluate hemolytic activity
  • Regularly monitor renal function parameters during hospitalization and post-discharge

Risks

  • G6PD deficiency increases risk of AKI independent of hemolytic events
  • AKI predicts higher mortality and risk of post-discharge kidney disease and cognitive impairment

Patient & Prescribing Data

Ugandan children aged 6 months to 4 years hospitalized with severe malaria

G6PD deficiency status should inform risk stratification for AKI; careful selection of medications to avoid hemolysis is critical

Clinical Best Practices

  • Incorporate G6PD genetic screening in pediatric severe malaria management protocols
  • Apply KDIGO criteria for early detection and diagnosis of AKI
  • Implement supportive care to maintain kidney perfusion and minimize oxidative stress
  • Educate caregivers on avoiding known hemolysis triggers in G6PD-deficient children
  • Conduct longitudinal follow-up for kidney function and neurocognitive outcomes post-discharge

References

Original Source(s)

Related Content